Notice of results

London, 18 July 2022 – Hikma Pharmaceuticals PLC (Hikma, Group), will announce its interim financial results for the six months ended 30 June 2022 on Thursday 4 August 2022.

Press Release Corporate 18 July 2022

A recording of the presentation will be available on the Group’s website at from 7:00am BST. Hikma will also hold a live Q&A conference call for analysts at 10:30am BST, and a recording will be made available on the Company’s website.

To join via conference call please dial:

United Kingdom toll-free: +44 800 640 6441

United Kingdom toll/international: +44 20 3936 2999

Access code: 155618

For further information please contact Tiina Lugmayer –

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.